AMBER KUNSHEK: Open Payments
NPI 1861508871 · LEES SUMMIT, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$844 in 46 payments from 13 companies in 2025. Trend: 2023 $1,224 · 2024 $642 · 2025 $844
Food & beverage: $844
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 7 | $158 |
| ABBVIE INC. | 12 | $158 |
| Arcutis Biotherapeutics, Inc. | 6 | $101 |
| Novartis Pharmaceuticals Corporation | 3 | $75 |
| Incyte Corporation | 2 | $53 |
| Amgen Inc. | 3 | $52 |
| Lilly USA, LLC | 3 | $49 |
| Janssen Biotech, Inc. | 3 | $48 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $43 |
| Regeneron Healthcare Solutions, Inc. | 2 | $43 |
Products named: Bimzelx, Zoryve, SKYRIZI, RINVOQ, OPZELURA, OTEZLA, TALTZ, DUPIXENT.
Industry payments across MO — which companies pay providers there.
